InMed Pharmaceuticals (INM) Treasury Shares (2023 - 2026)

InMed Pharmaceuticals' Treasury Shares history runs 4 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 8188.7% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 8188.7% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 734.35% from the prior year.
• Treasury Shares eased to $3.5 million in Q1 2026 per INM's latest filing, from $3.7 million in the prior quarter.
• Across five years, Treasury Shares topped out at $13.2 million in Q1 2024 and bottomed at $42096.0 in Q1 2025.
• The 4-year median for Treasury Shares is $559267.0 (2023), against an average of $2.8 million.
• Across the five-year window, Treasury Shares sank 99.68% in 2025 and jumped 8188.7% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $559267.0 in 2023, then tumbled by 91.56% to $47176.0 in 2024, then surged by 7826.09% to $3.7 million in 2025, then declined by 6.69% to $3.5 million in 2026.
• Per Business Quant, the three latest INM Treasury Shares figures stand at $3.5 million (Q1 2026), $3.7 million (Q4 2025), and $3.9 million (Q3 2025).